[26PS3-am] Drug delivery system in oncotherapy 1

Sun. Mar 26, 2023 10:35 AM - 11:59 AM [Room PS3] (2F)

Chair: Yuki Takahashi, Ikumi Sugiyama

+Add all to schedule

10:35 AM - 10:47 AM

[26PS3-am08] Development of a novel nano cancer therapy that induces the destruction of intratumoral vascular

○Rikito Endo¹, Takashi Nakamura¹, Yusuke Sato¹, Hideyoshi Harashima¹ (1. Faculty of Pharmaceutical Sciences, Hokkaido University.)

10:47 AM - 10:59 AM

[26PS3-am09S] Inhibition of tumor growth with CRISPR interference system induced by ultrasound-responsive nanobubbles

○Taiki Yamaguchi¹, Yoko Endo-Takahashi¹, Arina Ihara¹, Tetsushi Sakuma², Takashi Yamamoto², Takuya Fukazawa³, Yoichi Negishi¹ (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Grad. Sch. Sci. Life, Hiroshima Univ., 3. Kawasaki Med. Sch.)

10:59 AM - 11:11 AM

[26PS3-am10S] Development of effective cancer immunotherapy for Cold tumor

○Rie Kato¹, Lisa Munakata¹, Taiki Aoshi², Shohei Koyama^3,4, Daiki Omata¹, Yuno Suzuki¹, Yoshiaki Okada⁵, Yasuo Yoshioka^2,5,6,7,8, Ryo Suzuki^1,9 (1. Fac. Pharma-Sci., Teikyo University, 2. RIMD, Osaka University, 3. Grad. Sch. Med., Osaka University, 4. NCC-EPOC, 5. Grad. Sch. Pharm. Sci., Osaka University, 6. OTRI, Osaka University, 7. BIKEN Foundation, Osaka University, 8. MEI, Osaka University, 9. ACRO, Teikyo University)

11:11 AM - 11:23 AM

[26PS3-am11S] Antitumor effects by monotherapy of oxaliplatin-containing PEG-coated liposome and combination therapy with antibody drug in malignant lymphoma

○Takaya Sunami¹, Hidenori Ando¹, Yusuke Doi², Taro Shimizu¹, Yu Ishima¹, Masahiro Abe³, Tatsuhiro Ishida¹ (1. Grad. Sch. Pharm. Sci., Tokushima Univ., 2. Taiho Pharmaceutical Co., Ltd., 3. Grad. Sch. Med. Sci., Tokushima Univ.)

11:23 AM - 11:35 AM

[26PS3-am12] Development of brain tumor-accumulating anti-PD-L1 antibody using a detachable PEGylation technology

○Yuki Mochida¹, Tao Yang¹, Xueying Liu¹, Hiroaki Kinoh¹, Horacio Cabral², Kazunori Kataoka¹ (1. iCONM, Kawasaki Inst. Ind. Promotion, 2. Grad. Sch. Eng., The Univ. of Tokyo)

11:35 AM - 11:47 AM

[26PS3-am13S] Citrus lemon-derived extracellular vesicles as a nanocarrier for the treatment of glioma

○Susumu Suwabe¹, Koki Ogawa¹, Tatsuaki Tagami¹, Tetsuya Ozeki¹ (1. Grad. Sch. Pharm. Sci., Nagoya City Univ.)

11:47 AM - 11:59 AM

[26PS3-am14S] Involvement of autophagy inhibition in human pancreatic cancer cell death by nitrated phenylbutyric acid

○Yoshifumi Arimura¹, Koji Nishi^1,2, Takuro Beppu¹, Soma Morikawa¹, Ayana Matsumoto¹, Kenji Tsukigawa^1,2, Masaki Otagiri^1,2, Keishi Yamasaki^1,2 (1. Fac. Pharm. Sci., Sojo Univ., 2. DDS Res. Inst., Sojo Univ.)

Session information